aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. META
3. SPY
4. USO
5. VRTX
6. LGND
7. ONON
8. GS
9. PSKY
10. ARAI

Go back to aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
(NASDAQ: ATYR) Delayed: 0.37 --0 (-0%)
Previous Close $0.37    52 Week High $ 
Open $0.38    52 Week Low $ 
Day High $0.38    P/E N/A 
Day Low $0.37    EPS $ 
Volume 268,254